With a $3 million grant to the Translational Genomics Research Institute, the Ben and Catherine Ivy Foundation has launched an investigation into the gene patterns that could help researchers develop targeted drugs and diagnostics for brain cancer and allow doctors to personalize treatment for the disease.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.